Colorescience Overview
- Founded
-
2000

- Status
-
Private
- Employees
-
107

- Latest Deal Type
-
Debt Refin.
- Latest Deal Amount
-
$20M
- Investors
-
10
Colorescience General Information
Description
Operator of a skincare brand intended to offer dermatologist-recommended cosmetic products. The company's products are dermatologist endorsed containing healthy formulations and are made by meticulously refining minerals, pigments, and nutrient-dense ingredients which include minerals, antioxidants and botanicals, enabling women to achieve healthy skin and protect skin from the damaging effects of the sun.
Contact Information
Website
www.colorescience.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Personal Products
Other Industries
Internet Retail
Primary Office
- 2141 Palomar Airport Road
- Suite 200
- Carlsbad, CA 92011
- United States
+1 (866) 000-0000
Colorescience Timeline
Colorescience Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
16. Debt Refinancing | 03-Sep-2020 | $20M | 000.00 | Completed | Generating Revenue | |
15. Debt - PPP | 28-May-2020 | 00.000 | 000.00 | Completed | Generating Revenue | |
14. Later Stage VC (Series C) | 24-Jan-2020 | 000 | 000.00 | 0000 | Completed | Generating Revenue |
13. Debt Refinancing | 19-Nov-2018 | 000.00 | 000.00 | Completed | Generating Revenue | |
12. Later Stage VC (Series C) | 18-May-2018 | 000 | 0000 | 0000 | Completed | Generating Revenue |
11. Debt Refinancing | 31-Aug-2017 | 00.00 | 0000 | Completed | Generating Revenue | |
10. Later Stage VC (Series C) | 06-Jul-2017 | 0000 | 000.00 | 0000 | Completed | Generating Revenue |
9. Debt - General | 16-Feb-2016 | 00.00 | 000.00 | Completed | Generating Revenue | |
8. Secondary Transaction - Private | $25M | Completed | Startup | |||
7. Later Stage VC (Series B) | 10-Sep-2014 | $15M | $25M | 0000 | Completed | Startup |
Colorescience Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series B | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 | |
Series A | 24,832,270 | $0.000100 | $1.02 | $1.02 | 1x | $1.02 | 31.14% |
Colorescience Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of a skincare brand intended to offer dermatologist-recommended cosmetic products. The company's products are d
Personal Products
Carlsbad, CA
107
As of 2023
000.00
000000000 00
000.00
Colorescience Competitors (16)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Supergoop! | Private Equity-Backed | San Antonio, TX | 000 | 00.00 | 0000000 0000 | |
000 0000000 000000 | Corporate Backed or Acquired | London, United Kingdom | 00 | 000000&0 | ||
000 00000 00000000 | Corporate Backed or Acquired | London, United Kingdom | 000 | 000000&0 | ||
0000000 0000000 00 | Private Equity-Backed | Great Barrington, MA | 000 | 000000000000 | ||
000 0000 000000 | Private Equity-Backed | Denver, CO | 000 | 0000 | 00000000. 00 |
Colorescience Patents
Colorescience Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20210259950-A1 | Brightening skin care serums | Active | 12-Jun-2014 | 0000000000 | |
US-10285932-B2 | Skin care formulations | Active | 12-Jun-2014 | 0000000000 | |
US-20190240141-A1 | Redness correcting skin care formulations | Pending | 12-Jun-2014 | 0000000000 | 0 |
US-20180243206-A1 | Skin care formulations | Active | 12-Jun-2014 | 0000000000 | |
US-20220370338-A1 | Skin care formulations | Pending | 12-Jun-2014 | A61K8/9789 | 0 |
Colorescience Executive Team (20)
Colorescience Board Members (20)
Name | Representing | Role | Since |
---|---|---|---|
Adele Oliva | 1315 Capital | Board Member | 000 0000 |
David Olsen JD | Self | Board Member | 000 0000 |
Jessica Hou | Montreux Equity Partners | Board Member | 000 0000 |
Mary Fisher | Colorescience | Chief Executive Officer & Chairman | 000 0000 |
Nicky Kinnaird | Self | Board Member | 000 0000 |
Colorescience Signals
Colorescience Investors (10)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
K2 HealthVentures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Revelation Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
SightLine Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
Bridge Bank | Corporation | Minority | 000 0000 | 000000 0 | |
Hale BioPharma Ventures | Corporation | Minority | 000 0000 | 000000 0 |